NxThera CEO Bob Paulson Talks M&A, Career Twists, Family, and Lessons Learned from Selling Yogurt

Boston Scientific's acquisition of NxThera obviously signals an end of one era. The 10-year-old start-up will live inside the global giant, of course, but we ask CEO Bob Paulson what the sale means to him on a personal level. Paulson also walks us through his unorthodox career in marketing, corporate law, accounting, and finally leading a highly successful Medtech Start-Up.